Skip to main content
OpenTrials

Clinical trial condition

Secondary AML/MDS

Explore clinical trials studying Secondary AML/MDS. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Secondary AML/MDS trial results

Completed

POETIC Plerixafor as a Chemosensitizing Agent for Relapsed Acute Leukemia and MDS in Pediatric Patients

NCT01319864

Conditions
ALL, AML, Acute Leukemia of Ambiguous Lineage, +20 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • The Children's Hospital of Denver Denver, Colorado, United States
  • Children's Healthcare of Atlanta/Emory University Atlanta, Georgia, United States
  • Johns Hopkins Medical Center Baltimore, Maryland, United States
View Trial Details

Related conditions